Literature DB >> 12355005

Nonspecific interstitial pneumonia: correlation between thin-section CT findings and pathologic subgroups in 55 patients.

Takeshi Johkoh1, Nestor L Müller, Thomas V Colby, Kazuya Ichikado, Hiroyuki Taniguchi, Yasuhiro Kondoh, Kiminori Fujimoto, Masaharu Kinoshita, Hiroaki Arakawa, Hidehiro Yamada, Moritaka Suga, Masayuki Ando, Mitsuhiro Koyama, Hironobu Nakamura.   

Abstract

PURPOSE: To characterize thin-section computed tomographic (CT) findings of pathologic subgroups of nonspecific interstitial pneumonia (NIP) in a sizeable number of patients.
MATERIALS AND METHODS: The study included 55 cases of pathologically proven NIP. The 55 cases were categorized histologically into four grades: grade 1, interstitial inflammation without fibrosis (n = 6); grade 2, interstitial inflammation predominating over fibrosis (n = 16); grade 3, fibrosis predominating over inflammation (n = 5); and grade 4, fibrosis only (n = 28). Two independent observers evaluated the presence, extent, and distribution of various CT findings. Thin-section CT findings and histologic grades were compared by using the Spearman rank correlation coefficient. Observer agreement was assessed.
RESULTS: Areas with ground-glass attenuation and architectural distortion were present in all 55 patients. Traction bronchiectasis and intralobular reticular opacities were seen in 52 and 48 patients, respectively. The extent of traction bronchiectasis (r = 0.68; P <.001) and intralobular reticular opacities (r = 0.35; P <.05) correlated with the histologic grade. Honeycombing was seen in 12 (43%) of 28 patients with grade 4 NIP and in three (11%) of the remaining 27 patients (chi(2) test, P <.001). There was good agreement between the observers for the presence (kappa = 0.7-1.0) and extent (Spearman rank correlation; r = 0.87-0.98; P <.001) of various abnormalities.
CONCLUSION: The extent of traction bronchiectasis and intralobular reticulation at thin-section CT correlates with increased fibrosis in NIP. Honeycombing is seen almost exclusively in patients with fibrotic NIP.

Entities:  

Mesh:

Year:  2002        PMID: 12355005     DOI: 10.1148/radiol.2251011555

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  [Idiopathic interstitial pneumonias: from classification to diagnostic work-up].

Authors:  C Müller-Mang; L Stiebellehner; K Schmid; A Bankier
Journal:  Radiologe       Date:  2007-05       Impact factor: 0.635

Review 2.  Challenges in pulmonary fibrosis. 1: Use of high resolution CT scanning of the lung for the evaluation of patients with idiopathic interstitial pneumonias.

Authors:  Michael B Gotway; Michelle M Freemer; Talmadge E King
Journal:  Thorax       Date:  2007-06       Impact factor: 9.139

3.  The impact of slice-reduced computed tomography on histogram-based densitometry assessment of lung fibrosis in patients with systemic sclerosis.

Authors:  Thi Dan Linh Nguyen-Kim; Britta Maurer; Yossra A Suliman; Fabian Morsbach; Oliver Distler; Thomas Frauenfelder
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

4.  Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide.

Authors:  Hyun J Kim; Matthew S Brown; Robert Elashoff; Gang Li; David W Gjertson; David A Lynch; Diane C Strollo; Eric Kleerup; Daniel Chong; Sumit K Shah; Shama Ahmad; Fereidoun Abtin; Donald P Tashkin; Jonathan G Goldin
Journal:  Eur Radiol       Date:  2011-09-17       Impact factor: 5.315

5.  Post-operative acute exacerbation of pulmonary fibrosis in lung cancer patients undergoing lung resection.

Authors:  Motoki Yano; Hidefumi Sasaki; Satoru Moriyama; Yu Hikosaka; Keisuke Yokota; Susumu Kobayashi; Masaki Hara; Yoshitaka Fujii
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-24

6.  A preliminary study of lung abnormalities on HRCT in patients of rheumatoid arthritis-associated interstitial lung disease with progressive fibrosis.

Authors:  Luling Li; Shuai Gao; Qiang Fu; Ran Liu; Yongfeng Zhang; Xin Dong; Yifan Li; Min Li; Yi Zheng
Journal:  Clin Rheumatol       Date:  2019-07-13       Impact factor: 2.980

7.  Central paradiaphragmatic middle lobe involvement in nonspecific interstitial pneumonia.

Authors:  Joanna G Escalon; Alan C Legasto; Dennis Toy; James F Gruden
Journal:  Eur Radiol       Date:  2021-02-23       Impact factor: 5.315

8.  CT scan findings of probable usual interstitial pneumonitis have a high predictive value for histologic usual interstitial pneumonitis.

Authors:  Jonathan H Chung; Ashish Chawla; Anna L Peljto; Carlyne D Cool; Steve D Groshong; Janet L Talbert; David F McKean; Kevin K Brown; Tasha E Fingerlin; Marvin I Schwarz; David A Schwartz; David A Lynch
Journal:  Chest       Date:  2015-02       Impact factor: 9.410

9.  Quantitative assessment of change in regional disease patterns on serial HRCT of fibrotic interstitial pneumonia with texture-based automated quantification system.

Authors:  Ra Gyoung Yoon; Joon Beom Seo; Namkug Kim; Hyun Joo Lee; Sang Min Lee; Young Kyung Lee; Jae Woo Song; Jin Woo Song; Dong Soon Kim
Journal:  Eur Radiol       Date:  2012-08-24       Impact factor: 5.315

10.  An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias.

Authors:  William D Travis; Ulrich Costabel; David M Hansell; Talmadge E King; David A Lynch; Andrew G Nicholson; Christopher J Ryerson; Jay H Ryu; Moisés Selman; Athol U Wells; Jurgen Behr; Demosthenes Bouros; Kevin K Brown; Thomas V Colby; Harold R Collard; Carlos Robalo Cordeiro; Vincent Cottin; Bruno Crestani; Marjolein Drent; Rosalind F Dudden; Jim Egan; Kevin Flaherty; Cory Hogaboam; Yoshikazu Inoue; Takeshi Johkoh; Dong Soon Kim; Masanori Kitaichi; James Loyd; Fernando J Martinez; Jeffrey Myers; Shandra Protzko; Ganesh Raghu; Luca Richeldi; Nicola Sverzellati; Jeffrey Swigris; Dominique Valeyre
Journal:  Am J Respir Crit Care Med       Date:  2013-09-15       Impact factor: 21.405

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.